<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
    <journal-title-group>
      <journal-title>Genome Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1474-7596</issn>
    <issn pub-type="epub">1474-760X</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5004279</article-id>
    <article-id pub-id-type="publisher-id">1041</article-id>
    <article-id pub-id-type="doi">10.1186/s13059-016-1041-x</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Hannon</surname>
          <given-names>Eilis</given-names>
        </name>
        <address>
          <email>E.J.Hannon@exeter.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dempster</surname>
          <given-names>Emma</given-names>
        </name>
        <address>
          <email>E.L.Dempster@exeter.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Viana</surname>
          <given-names>Joana</given-names>
        </name>
        <address>
          <email>J.Viana@exeter.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Burrage</surname>
          <given-names>Joe</given-names>
        </name>
        <address>
          <email>J.Burrage@exeter.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Smith</surname>
          <given-names>Adam R.</given-names>
        </name>
        <address>
          <email>as541@exeter.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Macdonald</surname>
          <given-names>Ruby</given-names>
        </name>
        <address>
          <email>ruby.macdonald@keble.ox.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>St Clair</surname>
          <given-names>David</given-names>
        </name>
        <address>
          <email>d.stclair@abdn.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mustard</surname>
          <given-names>Colette</given-names>
        </name>
        <address>
          <email>10006535@uhi.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Breen</surname>
          <given-names>Gerome</given-names>
        </name>
        <address>
          <email>gerome.breen@kcl.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Therman</surname>
          <given-names>Sebastian</given-names>
        </name>
        <address>
          <email>Sebastian.therman@thl.fi</email>
        </address>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kaprio</surname>
          <given-names>Jaakko</given-names>
        </name>
        <address>
          <email>jaakko.kaprio@helsinki.fi</email>
        </address>
        <xref ref-type="aff" rid="Aff5">5</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Toulopoulou</surname>
          <given-names>Timothea</given-names>
        </name>
        <address>
          <email>timothea@hku.hk</email>
        </address>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pol</surname>
          <given-names>Hilleke E. Hulshoff</given-names>
        </name>
        <address>
          <email>H.E.Hulshoff@umcutrecht.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bohlken</surname>
          <given-names>Marc M.</given-names>
        </name>
        <address>
          <email>m.bohlken@umcutrecht.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kahn</surname>
          <given-names>Rene S.</given-names>
        </name>
        <address>
          <email>R.kahn@umcutrecht.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nenadic</surname>
          <given-names>Igor</given-names>
        </name>
        <address>
          <email>igor.nenadic@uni-jena.de</email>
        </address>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hultman</surname>
          <given-names>Christina M.</given-names>
        </name>
        <address>
          <email>Christina.Hultman@ki.se</email>
        </address>
        <xref ref-type="aff" rid="Aff11">11</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Murray</surname>
          <given-names>Robin M.</given-names>
        </name>
        <address>
          <email>robin.murray@kcl.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Collier</surname>
          <given-names>David A.</given-names>
        </name>
        <address>
          <email>collier_david_andrew@lilly.com</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff12">12</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bass</surname>
          <given-names>Nick</given-names>
        </name>
        <address>
          <email>n.bass@ucl.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff13">13</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gurling</surname>
          <given-names>Hugh</given-names>
        </name>
        <xref ref-type="aff" rid="Aff13">13</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>McQuillin</surname>
          <given-names>Andrew</given-names>
        </name>
        <address>
          <email>a.mcquillin@ucl.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff13">13</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schalkwyk</surname>
          <given-names>Leonard</given-names>
        </name>
        <address>
          <email>lschal@essex.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff14">14</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Mill</surname>
          <given-names>Jonathan</given-names>
        </name>
        <address>
          <email>J.Mill@exeter.ac.uk</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff15">15</xref>
      </contrib>
      <aff id="Aff1"><label>1</label>University of Exeter Medical School, University of Exeter, Exeter, UK </aff>
      <aff id="Aff2"><label>2</label>The Institute of Medical Sciences, Aberdeen University, Aberdeen, UK </aff>
      <aff id="Aff3"><label>3</label>University of the Highlands and Islands, Inverness, UK </aff>
      <aff id="Aff4"><label>4</label>Institute of Psychiatry, Psychology &amp; Neuroscience (IoPPN), King’s College London, London, UK </aff>
      <aff id="Aff5"><label>5</label>National Institute for Health and Welfare, Helsinki, Finland </aff>
      <aff id="Aff6"><label>6</label>Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland </aff>
      <aff id="Aff7"><label>7</label>Department of Public Health, University of Helsinki, Helsinki, Finland </aff>
      <aff id="Aff8"><label>8</label>Department of Psychology, The University of Hong Kong, Pokfulam, Hong Kong </aff>
      <aff id="Aff9"><label>9</label>Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands </aff>
      <aff id="Aff10"><label>10</label>Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany </aff>
      <aff id="Aff11"><label>11</label>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden </aff>
      <aff id="Aff12"><label>12</label>Eli Lilly and Company Ltd, Windlesham, UK </aff>
      <aff id="Aff13"><label>13</label>Division of Psychiatry, University College London, London, UK </aff>
      <aff id="Aff14"><label>14</label>School of Biological Sciences, University of Essex, Colchester, UK </aff>
      <aff id="Aff15"><label>15</label>Royal Devon &amp; Exeter Hospital, RILD Building, Level 4, Barrack Rd, Exeter, EX2 5DW UK </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>30</day>
      <month>8</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>30</day>
      <month>8</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2016</year>
    </pub-date>
    <volume>17</volume>
    <issue>1</issue>
    <elocation-id>176</elocation-id>
    <history>
      <date date-type="received">
        <day>13</day>
        <month>4</month>
        <year>2016</year>
      </date>
      <date date-type="accepted">
        <day>9</day>
        <month>8</month>
        <year>2016</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2016</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p>Schizophrenia is a highly heritable, neuropsychiatric disorder characterized by episodic psychosis and altered cognitive function. Despite success in identifying genetic variants associated with schizophrenia, there remains uncertainty about the causal genes involved in disease pathogenesis and how their function is regulated.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>We performed a multi-stage epigenome-wide association study, quantifying genome-wide patterns of DNA methylation in a total of 1714 individuals from three independent sample cohorts. We have identified multiple differentially methylated positions and regions consistently associated with schizophrenia across the three cohorts; these effects are independent of important confounders such as smoking. We also show that epigenetic variation at multiple loci across the genome contributes to the polygenic nature of schizophrenia. Finally, we show how DNA methylation quantitative trait loci in combination with Bayesian co-localization analyses can be used to annotate extended genomic regions nominated by studies of schizophrenia, and to identify potential regulatory variation causally involved in disease.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>This study represents the first systematic integrated analysis of genetic and epigenetic variation in schizophrenia, introducing a methodological approach that can be used to inform epigenome-wide association study analyses of other complex traits and diseases. We demonstrate the utility of using a polygenic risk score to identify molecular variation associated with etiological variation, and of using DNA methylation quantitative trait loci to refine the functional and regulatory variation associated with schizophrenia risk variants. Finally, we present strong evidence for the co-localization of genetic associations for schizophrenia and differential DNA methylation.</p>
      </sec>
      <sec>
        <title>Electronic supplementary material</title>
        <p>The online version of this article (doi:10.1186/s13059-016-1041-x) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Schizophrenia</kwd>
      <kwd>DNA methylation</kwd>
      <kwd>Epigenetics</kwd>
      <kwd>Genetics</kwd>
      <kwd>Polygenic risk score (PRS)</kwd>
      <kwd>Genome-wide association study (GWAS)</kwd>
      <kwd>Epigenome-wide association study (EWAS)</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Medical Research Council (GB)</institution>
        </funding-source>
        <award-id>MR/K013807/1</award-id>
        <principal-award-recipient>
          <name>
            <surname>Mill</surname>
            <given-names>Jonathan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
            <institution>National Institutes of Health</institution>
          </institution-wrap>
        </funding-source>
        <award-id>R01 AG036039</award-id>
        <principal-award-recipient>
          <name>
            <surname>Mill</surname>
            <given-names>Jonathan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group>
        <funding-source>
          <institution>Suomen Akatemia (FI)</institution>
        </funding-source>
        <award-id>213506</award-id>
        <award-id>129680</award-id>
        <award-id>265240</award-id>
      </award-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
            <institution>Suomen Akatemia</institution>
          </institution-wrap>
        </funding-source>
        <award-id>263278</award-id>
      </award-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004047</institution-id>
            <institution>Karolinska Institutet</institution>
          </institution-wrap>
        </funding-source>
        <award-id>ALF 20090183</award-id>
        <award-id>ALF 20100305</award-id>
        <principal-award-recipient>
          <name>
            <surname>Hultman</surname>
            <given-names>Christina M.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group>
        <funding-source>
          <institution>National Institutes of Health (US)</institution>
        </funding-source>
        <award-id>R01 MH52857</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2016</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1" sec-type="introduction">
    <title>Background</title>
    <p>Schizophrenia is a severe, highly heritable, neuropsychiatric disorder characterized by episodic psychosis and altered cognitive function. With a lifetime prevalence rate of ~1 %, schizophrenia contributes significantly to the global burden of disease, ranking amongst the top 10 causes of disability in developed countries worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. Schizophrenia has a highly complex etiology, aggregating in families but not segregating in a Mendelian manner. Recent approaches to understanding the causes of schizophrenia have focused on describing the genetic contribution to the disorder; the advent of large-scale genome-wide association studies (GWAS) and exome sequencing has enabled a systematic, hypothesis-free exploration of genetic risk factors. These “forward-genetics” approaches have been highly successful; a recent large-scale GWAS meta-analysis by the Psychiatric Genomics Consortium (PGC) identified 108 independent genomic loci exhibiting a genome-wide significant association with schizophrenia (<italic>P</italic> &lt; 5 × 10<sup>−8</sup>), with evidence for a substantial polygenic component in signals that fall below this stringent level of significance [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
    <p>Despite success in identifying genetic variants associated with schizophrenia, however, there remains uncertainty about the causal genes involved in disease pathogenesis, and how their function is regulated. Many GWAS variants reside in large regions of strong linkage disequilibrium (LD) and do not directly index coding changes affecting protein structure [<xref ref-type="bibr" rid="CR3">3</xref>]; instead, they are hypothesized to influence gene regulation, a hypothesis supported by the observation that common variants associated with disease are enriched in regulatory domains, including enhancers and regions of open chromatin [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Insights into the functional complexity of the genome have also focused attention on the probable role of non-sequence-based genomic variation in health and disease. Of particular interest are epigenetic processes that regulate gene expression via modifications to DNA, histone proteins, and chromatin. DNA methylation is the best-characterized epigenetic modification, stably influencing gene expression via disruption of transcription factor binding and recruitment of methyl-binding proteins that initiate chromatin compaction and gene silencing. Despite being traditionally regarded as a mechanism of transcriptional repression, DNA methylation is actually associated with both increased and decreased gene expression [<xref ref-type="bibr" rid="CR6">6</xref>], and other genomic functions including alternative splicing and promoter usage [<xref ref-type="bibr" rid="CR7">7</xref>]. The availability of high-throughput profiling methods for quantifying DNA methylation across the genome at single-base resolution in large numbers of samples has enabled researchers to perform epigenome-wide association studies (EWAS) aimed at identifying methylomic variation associated with environmental exposure and disease [<xref ref-type="bibr" rid="CR8">8</xref>]; however, these studies are inherently more complex to design and interpret than GWAS [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. The dynamic nature of epigenetic processes means that unlike in genetic epidemiology a range of potentially important confounding factors need to be considered, including tissue or cell type, age, sex, lifestyle exposures, and reverse causation [<xref ref-type="bibr" rid="CR9">9</xref>]. In recent years there has been a growing interest in the role of developmentally regulated epigenetic variation in the molecular etiology of schizophrenia, supported by data from recent analyses of DNA methylation in co-twins from disease-discordant monozygotic twin pairs [<xref ref-type="bibr" rid="CR12">12</xref>], clinical sample cohorts [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], and post-mortem brain tissue [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>].</p>
    <p>A better understanding of the molecular mechanisms underlying disease phenotypes is best achieved using an integrated functional genomics strategy, although few studies have attempted to systematically integrate genetic and epigenetic epidemiological approaches. For example, we previously demonstrated how DNA methylation is under local genetic control, identifying an enrichment of DNA methylation quantitative trait loci (mQTL) amongst genomic regions associated with schizophrenia, and highlighting how mQTLs can be used to refine GWAS loci by identifying discrete sites of regulatory variation associated with schizophrenia risk variants [<xref ref-type="bibr" rid="CR18">18</xref>]. There is also potential for using polygenic risk scores (PRS) – defined as the sum of trait-associated alleles across many genetic loci, weighted by effect sizes estimated by GWAS analyses – as disease biomarkers, although their utility for exploring the molecular genomic mechanisms involved in disease pathogenesis is largely unexplored. For example, PRS-associated epigenetic variation is potentially less affected by factors associated with the disease itself (e.g., medication exposure, stress, and smoking), which can confound case–control analyses.</p>
    <p>In this study we present a methodological framework for large EWAS and report widespread differences in DNA methylation between schizophrenia patients and controls in the largest analysis yet undertaken. Leveraging on previous investments in GWAS analyses in schizophrenia, we assessed genome-wide patterns of DNA methylation in a total of 1714 individuals from three independent sample cohorts to identify molecular biomarkers of the disease. Using genetic data from the same individuals, we performed an integrated genetic-epigenetic study to further our functional understanding of common variants associated with schizophrenia etiology. We demonstrate the utility of using PRS for identifying molecular variation associated with etiological variation, and mQTLs for refining the functional/regulatory variation associated with schizophrenia risk variants. Finally, we present strong evidence for the co-localization of genetic associations for schizophrenia and differential DNA methylation.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results and discussion</title>
    <sec id="Sec3">
      <title>Methodological overview</title>
      <p>We performed a multi-stage EWAS of (1) schizophrenia and (2) schizophrenia PRS, quantifying genome-wide patterns of DNA methylation using the Illumina Infinium HumanMethylation450 BeadChip (“450 K array”) (Illumina Inc., San Diego, CA, USA) in DNA samples isolated from whole blood. After implementing a stringent quality control pipeline (see <xref rid="Sec13" ref-type="sec">Methods</xref>), our “discovery cohort” (phase 1) included 675 individuals (353 schizophrenia cases and 322 non-psychiatric controls). Schizophrenia-associated differentially methylated positions (DMPs) were subsequently tested in an independent “replication cohort” (phase 2) of 847 individuals (414 schizophrenia cases and 433 non-psychiatric controls; phase 2) and 96 monozygotic (MZ) twin pairs (phase 3). We tested for a significant enrichment of schizophrenia-associated DMPs in regulatory regions, gene ontology (GO) pathways, and genomic regions identified in the recent PGC GWAS of schizophrenia [<xref ref-type="bibr" rid="CR2">2</xref>]. Finally, we integrated our genetic and epigenetic data to interrogate mQTLs across robust schizophrenia-associated GWAS regions, utilizing Bayesian co-localization analyses to identify genetic variants associated with both schizophrenia and methylomic variation. An overview of our methodological approach is presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1.</p>
    </sec>
    <sec id="Sec4">
      <title>Controlling for confounders in epigenetic epidemiology: smoking as an important covariate for schizophrenia EWAS</title>
      <p>Our initial analysis of the phase 1 cohort included covariates for sex and experimental batch, in addition to age and cell composition measures derived from the DNA methylation data [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. We identified 160 schizophrenia-associated DMPs at a stringent experiment-wide significance threshold (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) representing a 5 % family-wise error-rate estimated from 5000 permutations (see <xref rid="Sec13" ref-type="sec">Methods</xref>). The top-ranked DMPs were annotated to <italic>AHRR</italic> (cg05575921, cg21161138, cg26529655, cg25648203), <italic>F2RL3</italic> (cg03636183), <italic>GFI1</italic> (cg09935388), and <italic>MYO1G</italic> (cg12803068, cg22132788), in addition to intergenic regions on chromosome 6p21.33 (cg06126421, cg14753356) and 2q37.1 (cg01940273, cg05951221) (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1). Altered DNA methylation at each of these DMPs has been previously associated with cigarette smoking [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR24">24</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), consistent with epidemiological data highlighting elevated smoking rates and intensity in patients with schizophrenia [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. Because detailed smoking information was not available for every individual in the phase 1 cohort, we derived a proxy variable using DNA methylation values for sites on the 450 K array previously associated with smoking [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The resulting smoking scores were consistent with actual smoking status for samples with available smoking data, with current smokers having higher scores than non-smokers (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2). Across the full sample, DNA methylation-derived smoking scores were significantly higher in patients with schizophrenia compared to controls (Mann–Whitney <italic>P</italic> = 1.51 × 10<sup>−41</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3), consistent with epidemiological data [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>] and the results of our initial EWAS. We next repeated our schizophrenia EWAS analysis using these derived smoking scores as covariates; smoking-associated probes (<italic>P</italic> &lt; 1 × 10<sup>−7</sup> in [<xref ref-type="bibr" rid="CR22">22</xref>]) were no longer differentially methylated in the patients with schizophrenia (<italic>P</italic> &gt; 1 × 10<sup>−7</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4 and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2) with the exception of cg05575921 (annotated to <italic>AHRR</italic>; <italic>P</italic> = 1.62 × 10<sup>−14</sup>). Although it is possible that DNA methylation at this locus is associated with schizophrenia beyond the confounding effects of smoking, we took the final step of removing all smoking-associated probes from subsequent analyses to enable a clear interpretation of our data.<fig id="Fig1"><label>Fig. 1</label><caption><p>It is critical to control for smoking in an epigenome-wide association study (EWAS) of schizophrenia. Manhattan plots comparing association <italic>P</italic>-values (<italic>y</italic>-axis, −log10 scale) against genomic location (<italic>x</italic>-axis) for (<bold>a</bold>) an EWAS of schizophrenia case–control status without inclusion of a smoking covariate, (<bold>b</bold>) a published EWAS of tobacco smoking (never versus current) [<xref ref-type="bibr" rid="CR22">22</xref>], and (<bold>c</bold>) an EWAS of schizophrenia case–control status including a DNA methylation-derived smoking score as a covariate. There is considerable overlap between the associated loci in panels a and b (e.g., on chromosomes 2, 5, 6, and 19), implying that the elevated rate and intensity of smoking in patients with schizophrenia [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>] is a severe confounder in this analysis. In contrast, there is no overlap in the associated loci shown in panels b and c, suggesting that the derived smoking score effectively removes these false positives</p></caption><graphic xlink:href="13059_2016_1041_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>DMPs associated with schizophrenia are robust to additional confounding</title>
      <p>In total we identified 25 DMPs associated with schizophrenia passing our stringent experiment-wide significance threshold (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) when controlling for age, sex, experimental batch, and derived estimates of cell composition and smoking (Table <xref rid="Tab1" ref-type="table">1</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5). An additional 1223 DMPs were identified at a more relaxed “discovery” threshold of <italic>P</italic> &lt; 5 × 10<sup>−5</sup> (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3). Because it is likely that other unmeasured environmental exposures also confound our case–control analysis of methylomic variation associated with schizophrenia, we investigated the impact of additional surrogate variables capturing variation in DNA methylation on the association statistics for schizophrenia-associated DMPs. We first compared each of the first 10 principal components (PCs) derived from the DNA methylation data to the available phenotype data to identify potential sources of additional variation between samples (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6). For example, we observed strong correlations (<italic>r</italic> &gt; 0.5) between the first three PCs and estimated blood cell composition measures, reflecting the likely effect of epigenetic differences between cell types. Age was moderately correlated (<italic>r</italic> &gt; 0.2) with PCs 3, 8, and 9; sex was moderately correlated (<italic>r</italic> &gt; 0.2) with PCs 6 and 7; and smoking was weakly correlated (<italic>r</italic> &lt; 0.2) with each of the top 10 PCs. Although PCs are routinely included in GWAS analyses to control for population stratification, they have not been widely used in DNA methylation studies. We compared the regression coefficients from our initial analysis model (controlling for age, sex, batch, cell composition, and derived smoking score) to sequential models iteratively including up to 10 PCs. We observed a strong positive correlation for schizophrenia-associated DNA methylation differences between analyses (Spearman’s <italic>r</italic> = 0.629 to 0.820), with even stronger similarities observed for the top 1223 discovery schizophrenia-associated DMPs (Spearman’s <italic>r</italic> = 0.952 to 0.983) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7). Although additional (unmeasured) confounders are likely to exist in our dataset (e.g., medication exposures, drugs of abuse and stress), our sensitivity analyses showed that the identified schizophrenia-associated DMPs were relatively robust to the major PCs associated with methylomic variance in this dataset.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Schizophrenia-associated differentially methylated positions</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Probe ID</th><th>DNA methylation difference (%)</th><th><italic>P</italic> value</th><th>Chromosome</th><th>Base position</th><th colspan="2">Gene annotation</th></tr></thead><tbody><tr><td>cg10311104</td><td char="." align="char">0.80</td><td char="." align="char">9.75E−10</td><td>7</td><td>23053899</td><td>FAM126A</td><td>TSS200</td></tr><tr><td>cg08752433</td><td char="." align="char">2.78</td><td char="." align="char">1.05E−09</td><td>12</td><td>111016566</td><td>PPTC7</td><td>Body</td></tr><tr><td>cg26314722</td><td char="." align="char">1.85</td><td char="." align="char">1.73E−09</td><td>1</td><td>234867300</td><td/><td/></tr><tr><td>cg24054898</td><td char="." align="char">1.64</td><td char="." align="char">5.91E−09</td><td>3</td><td>148721868</td><td>GYG1</td><td>Body</td></tr><tr><td>cg23684410</td><td char="." align="char">2.40</td><td char="." align="char">6.13E−09</td><td>11</td><td>116897558</td><td>SIK3</td><td>Body</td></tr><tr><td>cg00945209</td><td char="." align="char">1.91</td><td char="." align="char">9.66E−09</td><td>17</td><td>76801579</td><td>USP36</td><td>Body</td></tr><tr><td>cg18518074</td><td char="." align="char">2.29</td><td char="." align="char">1.03E−08</td><td>11</td><td>64642316</td><td>EHD1</td><td>Body</td></tr><tr><td>cg09706133</td><td char="." align="char">1.23</td><td char="." align="char">1.31E−08</td><td>15</td><td>68659758</td><td>ITGA11</td><td>Body</td></tr><tr><td>cg21522988</td><td char="." align="char">2.06</td><td char="." align="char">1.80E−08</td><td>12</td><td>29376872</td><td>FAR2</td><td>5′UTR</td></tr><tr><td>cg02656560</td><td char="." align="char">1.69</td><td char="." align="char">3.14E−08</td><td>17</td><td>19967600</td><td/><td/></tr><tr><td>cg11418177</td><td char="." align="char">2.03</td><td char="." align="char">3.50E−08</td><td>4</td><td>142636072</td><td>IL15</td><td>5′UTR</td></tr><tr><td>cg06736148</td><td char="." align="char">2.14</td><td char="." align="char">3.68E−08</td><td>15</td><td>52416833</td><td>GNB5</td><td>Body</td></tr><tr><td>cg08655071</td><td char="." align="char">1.74</td><td char="." align="char">4.74E−08</td><td>1</td><td>209928895</td><td>TRAF3IP3</td><td>TSS1500</td></tr><tr><td>cg00829438</td><td char="." align="char">−1.02</td><td char="." align="char">5.26E−08</td><td>9</td><td>136213035</td><td>MED22</td><td>Body</td></tr><tr><td>cg27541604</td><td char="." align="char">1.65</td><td char="." align="char">5.57E−08</td><td>1</td><td>159046451</td><td>AIM2</td><td>5′UTR;1stExon</td></tr><tr><td>cg03149593</td><td char="." align="char">−1.24</td><td char="." align="char">5.98E−08</td><td>3</td><td>136988095</td><td/><td/></tr><tr><td>cg14178364</td><td char="." align="char">1.44</td><td char="." align="char">6.43E−08</td><td>9</td><td>37529128</td><td>FBXO10</td><td>Body</td></tr><tr><td>cg14038731</td><td char="." align="char">1.42</td><td char="." align="char">6.70E−08</td><td>6</td><td>110732536</td><td>DDO</td><td>Body</td></tr><tr><td>cg20737259</td><td char="." align="char">−3.09</td><td char="." align="char">7.79E−08</td><td>4</td><td>95038723</td><td/><td/></tr><tr><td>cg09470958</td><td char="." align="char">1.20</td><td char="." align="char">8.35E−08</td><td>6</td><td>31055471</td><td/><td/></tr><tr><td>cg13803727</td><td char="." align="char">1.43</td><td char="." align="char">8.65E−08</td><td>9</td><td>89445247</td><td/><td/></tr><tr><td>cg03402926</td><td char="." align="char">1.72</td><td char="." align="char">8.77E−08</td><td>11</td><td>27340767</td><td/><td/></tr><tr><td>cg07326387</td><td char="." align="char">−2.10</td><td char="." align="char">9.16E−08</td><td>4</td><td>44543613</td><td/><td/></tr><tr><td>cg00092992</td><td char="." align="char">1.80</td><td char="." align="char">9.69E−08</td><td>1</td><td>33596100</td><td/><td/></tr><tr><td>cg03665078</td><td char="." align="char">1.58</td><td char="." align="char">9.98E−08</td><td>5</td><td>118689961</td><td>TNFAIP8</td><td>Body</td></tr></tbody></table><table-wrap-foot><p>Listed are all differentially methylated positions (DMPs) associated with schizophrenia (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) with the corresponding <italic>P</italic> values and regression coefficients from the phase 1 discovery cohort. All DMPs with <italic>P</italic> &lt; 5 × 10<sup>−5</sup> are listed in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3 with the corresponding <italic>P</italic> values and regression coefficients for the two independent replication cohorts</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec6">
      <title>Evidence of coordinated differential DNA methylation associated with schizophrenia across genomic regions</title>
      <p>We next sought to identify extended regions characterized by schizophrenia-associated DNA methylation differences spanning multiple Illumina 450 K probes, implementing two methodological approaches to define differentially methylated regions (DMRs). First, we employed the <italic>comb-p</italic> algorithm that corrects the DMP <italic>P</italic> values for auto-correlation between probes and then scans the genome for peaks of association around a seed signal (set to <italic>P</italic> &lt; 5 × 10<sup>−5</sup>) [<xref ref-type="bibr" rid="CR28">28</xref>]. For each region it calculates the Stouffer–Liptak corrected <italic>P</italic> value, which is then adjusted for multiple testing using Šidák’s correction. This approach identified 12 significant schizophrenia-associated DMRs (Šidák-corrected <italic>P</italic> &lt; 0.05) spanning between 2 and 20 DNA methylation sites (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S4). The top-ranked DMR identified using this approach spanned 20 CpG sites overlapping the major histocompatibility complex (MHC) on chromosome 6, noteworthy as it is the most robustly associated locus in schizophrenia GWAS [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. Second, in order to identify groups of sites that may not contain highly significant individual DMPs but are instead characterized by an extended region of contiguous differential DNA methylation associated with schizophrenia, we used a sliding window approach (see <xref rid="Sec13" ref-type="sec">Methods</xref>) [<xref ref-type="bibr" rid="CR33">33</xref>], using permutations to establish an appropriate multiple testing threshold (set at <italic>P</italic> &lt; 3 × 10<sup>−7</sup> for 5 % family-wise error). We identified 531 schizophrenia-associated regions, which were filtered to a set of 76 non-overlapping regions (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S5). Three of the 12 DMRs identified by <italic>comb-p</italic> were also identified as DMRs using this sliding window approach. The 76 DMRs contained between 2 and 120 probes (median 8.5), with the DMR <italic>P</italic> value not biased by the number of probes within each region (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8). Of note, 30 (36 %) of these genomic regions were not implicated by the probe-wise analysis, and for the majority (96 %) of regions, the DMR <italic>P</italic> values were more significant than the best individual probe <italic>P</italic> value, suggesting that there might be multiple semi-independent DMPs in these regions (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S9). The top DMR (<italic>P</italic> = 1.87 × 10<sup>−14</sup>) identified using this approach spanned three probes within <italic>GYG1</italic> on chromosome 3 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10), a gene previously shown to be differentially expressed in prefrontal pyramidal neurons from patients with schizophrenia [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
    </sec>
    <sec id="Sec7">
      <title>Schizophrenia-associated DMPs are enriched in transcription factor binding sites and in the vicinity of genes involved in immune-related pathways</title>
      <p>We investigated whether the 1223 phase 1 discovery DMPs (<italic>P</italic> &lt; 5 × 10<sup>−5</sup>) are enriched in specific regulatory domains identified in the ENCODE project [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. We found no significant enrichment of DMPs within DNAse I hypersensitivity sites (DHS) (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S6; <italic>P</italic> &gt; 0.05) and a significant depletion of DMPs in the broad set of transcription factor binding sites [odds ratio (OR) = 0.852, <italic>P</italic> = 0.00542]. We identified a significant enrichment (<italic>P</italic> &lt; 0.00338; corrected for 148 transcription factors) in certain specific transcription factor binding motifs including BATF (OR = 4.90, <italic>P</italic> = 5.04 × 10<sup>−16</sup>), BCL11A (OR = 3.48, <italic>P</italic> = 2.08 × 10<sup>−7</sup>), IRF4 (M-17) (OR = 2.20, <italic>P</italic> = 1.71 × 10<sup>−5</sup>), and MEF2A (OR = 2.13, <italic>P</italic> = 3.04 × 10<sup>−5</sup>), and a significant depletion in HA-E2F1 binding-sites (OR = 0.701, <italic>P</italic> = 0.000319). In order to investigate functional relationships between the 955 genes annotated to the 1223 phase 1 discovery DMPs, we tested for an over-representation of ontological categories and pathways using a method that controls for the number of probes annotated to each gene on the 450 K array (see <xref rid="Sec13" ref-type="sec">Methods</xref>). Given the hierarchical structure of the ontological annotations, many of the significant terms are not independent and are associated by virtue of their overlapping membership; we therefore sought to group terms where the significant enrichment was explained by the overlap with a more significant term (see <xref rid="Sec13" ref-type="sec">Methods</xref>), identifying 153 groups of related GO categories (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S7). The top-ranked group of pathways were related to immune function, consistent with findings from genetic [<xref ref-type="bibr" rid="CR37">37</xref>], transcriptomic [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>], and epidemiological data [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. The second-ranked group of pathways were related to neuronal proliferation and brain development, an interesting observation given the hypothesized neurodevelopmental origins of schizophrenia [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
    </sec>
    <sec id="Sec8">
      <title>Replication of schizophrenia-associated DMPs in two independent cohorts</title>
      <p>We next sought to confirm the identified schizophrenia-associated differences in an independent replication sample (phase 2) by generating 450 K array data from an additional 414 patients with schizophrenia and 433 non-psychiatric controls. As with the phase 1 cohort, patients with schizophrenia were characterized by a significantly higher smoking score derived from Illumina 450 K array DNA methylation data (Mann–Whitney <italic>P</italic> = 1.15 × 10<sup>−22</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3). We therefore employed an analysis model controlling for age, sex, batch, cell composition, and smoking to identify schizophrenia-associated differences at nominated DMPs. The 25 experiment-wide significant (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) DMPs identified in phase 1 were characterized by highly consistent schizophrenia-associated differences in the same direction in the phase 2 dataset (sign test <italic>P</italic> = 7.75 × 10<sup>−7</sup>) (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>); 14 of these DMPs were characterized by experiment-wide significant (<italic>P</italic> &lt; 1 × 10<sup>-7</sup>) differences in the same direction in phase 2, with five additional DMPs significant at <italic>P</italic> &lt; 5 × 10<sup>−5</sup>. The phase 1 discovery DMPs (<italic>P</italic> &lt; 5 × 10<sup>−5</sup>) were also characterized by highly consistent schizophrenia-associated differences in phase 2, with 1159 (94.8 %) having a consistent direction of effect (sign test <italic>P</italic> = 4.25 × 10<sup>−261</sup>). Of the phase 1 DMPs, 137 (11.2 %), 249 (20.4 %), and 245 (20.0 %) were associated at <italic>P</italic> &lt; 1 × 10<sup>−7</sup>, <italic>P</italic> &lt; 5 × 10<sup>−5</sup>, and <italic>P</italic> &lt; 4.09 × 10<sup>−5</sup> (correcting for 1223 DMPs) respectively (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3).<fig id="Fig2"><label>Fig. 2</label><caption><p>Replication of schizophrenia-associated DNA methylation differences identified in the phase 1 analysis in two independent cohorts. Shown are scatterplots demonstrating the concordance in effect size [schizophrenia-associated DNA methylation difference (%)] between the phase 1 (case–control) cohort (<italic>n</italic> = 675) (<italic>x</italic>-axis) and either the (<bold>a</bold>) phase 2 (case–control) cohort (<italic>n</italic> = 847) or (<bold>b</bold>) phase 3 (<italic>n</italic> = 96 monozygotic twin pairs) cohort for probes associated with schizophrenia at both the experiment-wide (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>; <italic>red circles</italic>) and discovery (<italic>P</italic> &lt; 5 × 10<sup>−5</sup>; <italic>blue triangles</italic>) <italic>P</italic>-value thresholds. Many of these individual DNA methylation sites are significantly associated with schizophrenia in the replication cohorts (Table <xref rid="Tab1" ref-type="table">1</xref> and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3). Meta-analyses across the three independent cohorts identified many additional sites significantly associated with schizophrenia at <italic>P</italic> &lt; 1 × 10<sup>−7</sup>. (<bold>c</bold>) A forest plot of the top ranked probe from the meta-analysis (cg02488934), with the effect size and standard error (<italic>SE</italic>) from each individual cohort and the pooled effect from the meta-analysis. <italic>CI</italic> confidence interval</p></caption><graphic xlink:href="13059_2016_1041_Fig2_HTML" id="MO2"/></fig></p>
      <p>We next tested the schizophrenia-associated DMPs from phase 1 in a sample of 96 monozygotic twin pairs (phase 3); the analysis of MZ twins is a powerful tool in epigenetic epidemiology, as they do not differ for many of the confounders that can influence case–control analyses (e.g., age, sex, genotype) [<xref ref-type="bibr" rid="CR9">9</xref>]. Although none of the top-ranked phase 1 DMPs (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) reached experiment-wide significance in the twin dataset (minimum <italic>P</italic> = 1.11 × 10<sup>−4</sup>; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3), this is not surprising given the relatively small number of twin pairs, and schizophrenia-associated differences were highly correlated with those identified in phase 1. Strikingly, 24 out of 25 (96 %) experiment-wide significant DMPs (sign test <italic>P</italic> = 7.75 × 10<sup>−7</sup>) and 1113 out of 1216 (91.5 %) phase 1 discovery DMPs (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>; sign test <italic>P</italic> = 6.47 × 10<sup>−215</sup>) were characterized by schizophrenia-associated differences in the same direction, demonstrating that these effects were not confounded by factors such as genotype and sex that are perfectly matched between genetically identical twins. Finally, a meta-analysis across the three independent datasets demonstrated that 22 out of 25 (88 %) of the phase 1 experiment-wide significant DMPs were characterized by an experiment-wide significant association across all cohorts, with an additional 343 experiment-wide DMPs (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) identified in the combined meta-analysis (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S8, and Additional file <xref rid="MOESM3" ref-type="media">3</xref>).</p>
    </sec>
    <sec id="Sec9">
      <title>Differential DNA methylation associated with polygenic burden for schizophrenia</title>
      <p>Many common DNA sequence variants, each conferring a small effect on susceptibility, mediate risk for schizophrenia [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Beyond the specific genome-wide significant loci identified in GWAS, an individual’s accumulated genetic burden can be quantified to define an overall PRS – that is, the sum of trait-associated alleles across many genetic loci, weighted by effect sizes estimated by GWAS analyses [<xref ref-type="bibr" rid="CR43">43</xref>]. It has been suggested that an individual’s PRS may function as a less confounded phenotype for molecular epidemiology, quantitatively indexing underlying neurobiological phenotypes associated with susceptibility. Schizophrenia PRSs were calculated for 639 samples in the phase 1 cohort based on genetic association data from the recent large PGC GWAS analysis of schizophrenia [<xref ref-type="bibr" rid="CR2">2</xref>] (see <xref rid="Sec13" ref-type="sec">Methods</xref>). As expected, patients with schizophrenia had a significantly higher PRS than control samples (<italic>P</italic> = 3.34 × 10<sup>−27</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S12), confirming a higher polygenic burden of common risk variants in this group. We next performed an EWAS of the schizophrenia PRS, using a linear model controlling for the covariates of age, sex, and cell counts derived from the DNA methylation data, but not smoking status (see <xref rid="Sec13" ref-type="sec">Methods</xref>). Unlike the analysis of schizophrenia diagnosis, we did not see an enrichment of smoking-associated DMPs (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S13 and S14), indicating that increased smoking rates in schizophrenia might not result from the underlying common polygenic architecture of the disease. Performing a sensitivity analysis using PCs derived from the DNA methylation data iteratively (as described above) highlighted similar strong correlations (<italic>r</italic> = 0.963–0.980) with the effects identified in the initial EWAS (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S15). Two DMPs were associated with schizophrenia PRS at our experiment-wide significance threshold (<italic>P</italic> &lt; 1 × 10<sup>–7</sup>), with 156 DMPs identified at the more relaxed discovery threshold of <italic>P</italic> &lt; 5 × 10<sup>−5</sup> (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S9). Of note, the top-ranked disease- and PRS-associated DMPs are distinct, with no site reaching experiment-wide significance in both analyses (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). Given our previous finding that there is an enrichment of mQTLs amongst SNPs associated with schizophrenia [<xref ref-type="bibr" rid="CR18">18</xref>], we investigated whether any of the PRS-associated DMPs resulted directly from such genetic associations. Performing an mQTL analysis for all genetic variants incorporated in the PRS, we identified no overlap with DNA methylation sites associated with PRS. We next investigated PRS-associated DMPs in samples from our phase 2 replication cohort for whom genotype data were available (<italic>n</italic> = 843), in which patients with schizophrenia were again characterized by a significantly higher schizophrenia PRS than controls (<italic>P</italic> = 2.09 × 10<sup>−31</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S12). Although none of the 156 DMPs reached experiment-wide significance in the phase 2 dataset (minimum <italic>P</italic> = 0.000121; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S9), effect sizes were again strongly correlated and there was a significant excess of consistent changes across both cohorts (123/156 sign test <italic>P</italic> = 1.05 × 10<sup>−13</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S16).<fig id="Fig3"><label>Fig. 3</label><caption><p>There is minimal overlap between significant schizophrenia-associated differentially methylated positions and those associated with the schizophrenia polygenic risk score (<italic>PRS</italic>). Shown is a scatterplot comparing probe-wise significance in the epigenome-wide association study (<italic>EWAS</italic>) of schizophrenia case status (<italic>x</italic>-axis) and PRS (<italic>y</italic>-axis). Data are presented for probes identified as significant (P &lt; 5 × 10<sup>−5</sup>) in the schizophrenia EWAS (<italic>red circles</italic>), PRS EWAS (<italic>blue triangles</italic>), or both (<italic>green diamonds</italic>)</p></caption><graphic xlink:href="13059_2016_1041_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Differentially methylated sites overlap schizophrenia GWAS loci</title>
      <p>We next examined whether there is any overlap between the location of DMPs identified in this study and the 105 autosomal genomic regions nominated by the recent GWAS of schizophrenia [<xref ref-type="bibr" rid="CR2">2</xref>]. These regions were derived by the PGC by “clumping” the GWAS <italic>P</italic> values so that multiple non-independent associations were collapsed into a single associated loci. Briefly, we generated a combined differential methylation <italic>P</italic> value from the individual probes, taking into account the correlation structure between them [<xref ref-type="bibr" rid="CR33">33</xref>] (see <xref rid="Sec13" ref-type="sec">Methods</xref>); 76 of the GWAS regions contained more than one 450 K array probe (median = 35, range = 2–504) and were appropriate for generating a combined <italic>P</italic> value. From these, we identified 27 regions (35.5 %) that demonstrated significant differences in DNA methylation (Bonferroni corrected threshold <italic>P</italic> &lt; 0.000658; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S10) in schizophrenia samples compared to controls, of which nine were also characterized by a significant combined PRS EWAS <italic>P</italic> value. The top region is plotted in Fig. <xref rid="Fig4" ref-type="fig">4</xref>, highlighting multiple sites of differential DNA methylation across the whole LD block. Because these regions were larger than those considered for the sliding window approach, we generated empirical <italic>P</italic> values (see <xref rid="Sec13" ref-type="sec">Methods</xref>) to confirm significant associations across 25 of the 27 schizophrenia-associated regions and four of nine PRS-associated regions. In all of these DMRs, the combined <italic>P</italic> value was more significant than the best DMP <italic>P</italic> value (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S17), suggesting that there might be multiple semi-independently associated differentially methylated sites across these regions. Taken together, these results support previous findings that schizophrenia-associated DNA methylation differences overlap with genetic susceptibility loci [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].<fig id="Fig4"><label>Fig. 4</label><caption><p>Evidence for schizophrenia-associated differential DNA methylation within genome-wide association study (<italic>GWAS</italic>)-nominated genomic regions. A Manhattan plot of an example genomic region (chr10:104423800-105165583) identified in the recent GWAS of schizophrenia [<xref ref-type="bibr" rid="CR2">2</xref>] illustrates the location (<italic>x</italic>-axis) of genetic variants and Illumina 450 K probes against their significance with schizophrenia (<italic>y</italic>-axis; −log10 <italic>P</italic> value). Gene locations (exons and introns) are depicted above the Manhattan plot. <italic>Red diamonds</italic> depict GWAS results, <italic>green circles</italic> depict results from our phase 1 schizophrenia EWAS, and <italic>blue triangles</italic> depict results from our schizophrenia polygenic risk score EWAS</p></caption><graphic xlink:href="13059_2016_1041_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Evidence that schizophrenia GWAS signals co-localize with mQTLs</title>
      <p>Although an enrichment of schizophrenia-associated DMPs in regions identified in GWAS is consistent with DNA methylation mediating the relationship between common risk variants and pathogenesis, this association does not establish a direct causal link. Motivated by this, we performed a Bayesian co-localization analysis [<xref ref-type="bibr" rid="CR46">46</xref>] in phase 1 samples for which both genetic and DNA methylation data were available (<italic>n</italic> = 639). Briefly, this approach compares the pattern of association results from two independent GWAS (i.e. of schizophrenia and DNA methylation) to see if they are indexing an association with the same causal variant. We considered mQTL data for 23,649 unique Illumina 450 K probes located within 500 kb of the 105 autosomal GWAS-nominated regions defined by the PGC [<xref ref-type="bibr" rid="CR2">2</xref>]. Because some probes were located in more than one GWAS region, we assessed a total of 23,918 potential mQTL pairs with schizophrenia. The posterior probabilities for 80 regions, involving DNA methylation sites in 1375 mQTL pairs, are supportive of a co-localized association signal for both schizophrenia and DNA methylation in that region (PP<sub>3</sub> + PP<sub>4</sub> &gt; 0.99; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S11). Of these pairs, 127 (covering 39 regions associated with schizophrenia) had a higher posterior probability for both schizophrenia and DNA methylation, being associated with the same causal variant (PP<sub>4</sub>/PP<sub>3</sub> &gt; 1), with 66 (over 27 regions) of these having sufficient support for them to be considered as “convincing” (PP<sub>4</sub>/PP<sub>3</sub> &gt; 5) according to the criteria of Guo and colleagues [<xref ref-type="bibr" rid="CR47">47</xref>]. We next compared these results to a similar analysis performed in a smaller sample of post-mortem brains [<xref ref-type="bibr" rid="CR18">18</xref>]. Of 16 convincing pairs identified in brain, nine also had evidence of a co-localized association signal (PP<sub>3</sub> + PP<sub>4</sub> &gt; 0.99) for both schizophrenia and DNA methylation in blood, seven (44 %) of which were also classed as demonstrating convincing co-localization with blood mQTLs (Table <xref rid="Tab2" ref-type="table">2</xref>). One such example of this is shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>, highlighting a similar profile of GWAS <italic>P</italic> values across the region for schizophrenia and the mQTL in both blood and brain (additional examples are presented in Additional file <xref rid="MOESM4" ref-type="media">4</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Convincing co-localization of schizophrenia and DNA methylation genome-wide association study signals in blood and brain</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Schizophrenia GWAS region</th><th rowspan="3">Probe ID</th><th rowspan="3">Chr</th><th rowspan="3">Base position</th><th rowspan="3">Gene annotation</th><th colspan="6">Bayesian co-localization</th></tr><tr><th colspan="3">mQTL in blood</th><th colspan="3">mQTL in brain</th></tr><tr><th>nsnps</th><th>PP3 + PP4</th><th>PP4/PP3</th><th>nsnps</th><th>PP3 + PP4</th><th>PP4/PP3</th></tr></thead><tbody><tr><td>108</td><td>cg00585072</td><td>5</td><td>140186983</td><td>PCDHA2;PCDHA1;PCDHA4;PCDHA3</td><td>1595</td><td>0.9982</td><td>5.340</td><td>1260</td><td>0.9983</td><td>6.058</td></tr><tr><td>7</td><td>cg02951883</td><td>7</td><td>2050386</td><td>MAD1L1</td><td>1808</td><td>1.0000</td><td>14.596</td><td>2144</td><td>0.9992</td><td>11.820</td></tr><tr><td>3</td><td>cg08772003</td><td>10</td><td>104629869</td><td>AS3MT</td><td>1994</td><td>1.0000</td><td>51.075</td><td>1316</td><td>1.0000</td><td>36.981</td></tr><tr><td>3</td><td>cg11784071</td><td>10</td><td>104629166</td><td>AS3MT</td><td>1994</td><td>0.9999</td><td>8.046</td><td>1315</td><td>1.0000</td><td>39.298</td></tr><tr><td>3</td><td>cg24592962</td><td>10</td><td>104629151</td><td>AS3MT</td><td>1994</td><td>0.9986</td><td>36.510</td><td>1315</td><td>1.0000</td><td>55.055</td></tr><tr><td>99</td><td>cg14258853</td><td>12</td><td>29935411</td><td>TMTC1</td><td>3551</td><td>0.9995</td><td>46.932</td><td>2598</td><td>0.9989</td><td>10.723</td></tr><tr><td>47</td><td>cg26732615</td><td>19</td><td>19648335</td><td>CILP2;YJEFN3</td><td>1644</td><td>1.0000</td><td>8.196</td><td>1285</td><td>0.9906</td><td>5.514</td></tr></tbody></table><table-wrap-foot><p>Listed are all instances where the GWAS results indicate that the same causal variant is associated with schizophrenia and DNA methylation at a specific site in both blood and brain. Bayesian co-localization analysis compared the GWAS results evaluating the evidence for five hypotheses (see <xref rid="Sec13" ref-type="sec">Methods</xref>); convincing co-localization signs were defined as PP3 + PP4 &gt; 0.99 and PP4/PP3 &gt; 5. The full set of results for all genetic loci associated with schizophrenia can be found in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S12.</p><p><italic>Chr</italic> chromosome, <italic>GWAS</italic> genome-wide association study; <italic>mQTL</italic> DNA methylation quantitative trait loci; <italic>nsnps </italic>number of SNPs</p></table-wrap-foot></table-wrap><fig id="Fig5"><label>Fig. 5</label><caption><p>Co-localization of genome-wide association study (GWAS) signals associated with both schizophrenia and DNA methylation in blood and brain. Manhattan plots illustrate the location of genetic variants (<italic>x</italic>-axis) and their significance (<italic>y</italic>-axis; −log10 scale) in GWAS of schizophrenia (<bold>a</bold>), and DNA methylation at cg24592962 in blood (<bold>b</bold>) and brain (<bold>c</bold>). The <italic>solid red line</italic> indicates the location of the DNA methylation site (cg24592962). Comparing the pattern of these results for the mQTL and schizophrenia is supportive of the same causal variant being associated with both. Other examples are presented in Additional file <xref rid="MOESM4" ref-type="media">4</xref>
</p></caption><graphic xlink:href="13059_2016_1041_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec12" sec-type="conclusion">
    <title>Conclusions</title>
    <p>This study is the first systematic integrated analysis of genetic and epigenetic variation in schizophrenia, introducing a methodological pipeline that can be used to inform EWAS analyses of other traits and diseases. We have identified multiple DMPs and DMRs associated with schizophrenia, independently of important confounders such as smoking, with striking levels of replication in independent sample cohorts. We also show that polygenic burden for schizophrenia is associated with epigenetic variation across the genome, independently of loci implicated in the analysis of diagnosed schizophrenia. Finally, we have used mQTL analyses to annotate the extended genomic regions nominated by GWAS analyses of schizophrenia, using co-localization analyses to highlight potential regulatory variation causally involved in disease.</p>
  </sec>
  <sec id="Sec13" sec-type="materials|methods">
    <title>Methods</title>
    <p>All experimental methods were in accordance with the Helsinki declaration.</p>
    <sec id="Sec14">
      <title>Cohort description: phase 1- University College London</title>
      <p>The University College London case–control sample has been described elsewhere [<xref ref-type="bibr" rid="CR48">48</xref>] but briefly comprises of unrelated ancestrally matched cases and controls from the UK. Case participants were recruited from UK National Health Service (NHS) mental health services with a clinical International Classification of Diseases 10th edition (ICD-10) diagnosis of schizophrenia. All case participants were interviewed with the Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L) [<xref ref-type="bibr" rid="CR49">49</xref>] to confirm Research Diagnostic Criteria (RDC) diagnosis. A control sample screened for an absence of mental health problems was recruited. Each control subject was interviewed to confirm that they did not have a personal history of an RDC-defined mental disorder or a family history of schizophrenia, bipolar disorder, or alcohol dependence. UK NHS multicenter and local research ethics approval was obtained and all participants signed an approved consent form after reading an information sheet.</p>
    </sec>
    <sec id="Sec15">
      <title>Cohort description: phase 2 – Aberdeen</title>
      <p>The Aberdeen case–control sample has been described elsewhere [<xref ref-type="bibr" rid="CR50">50</xref>] but briefly contains patients with schizophrenia and controls who have self-identified as born in the British Isles (95 % in Scotland). All cases met the Diagnostic and Statistical Manual for Mental Disorders fourth edition (DSM-IV) and ICD-10 criteria for schizophrenia. Diagnosis was made by Operational Criteria Checklist (OPCRIT). All case participants were outpatients or stable inpatients. Detailed medical and psychiatric histories were collected. A clinical interview using the Structured Clinical Interview for DSM-IV (SCID) was also performed on schizophrenia cases. Controls were volunteers recruited through general practices in Scotland. Practice lists were screened for potentially suitable volunteers by age and sex and by exclusion of individuals with major mental illness or use of neuroleptic medication. Volunteers who replied to a written invitation were interviewed using a short questionnaire to exclude major mental illness in the individual themselves and their first-degree relatives. All cases and controls gave informed consent. The study was approved by both local and multiregional academic ethical committees.</p>
    </sec>
    <sec id="Sec16">
      <title>Cohort description: phase 3 – monozygotic twins</title>
      <p>The MZ twin cohort is a multi-center collaborative project aimed at identifying DNA methylation differences in MZ twin pairs discordant for schizophrenia. We identified 96 informative twin-pairs (<italic>n</italic> = 192 individuals) from European twin studies based in Utrecht (The Netherlands), Helsinki (Finland), London (UK), Stockholm (Sweden), and Jena (Germany). Of the MZ twin pairs utilized in the analysis, 75 were discordant for diagnosed schizophrenia, six were concordant for schizophrenia, and 15 twin pairs were free of any psychiatric disease. In this analysis we tested specific DNA methylation probes nominated from our case–control analysis; a more detailed description of the cohort along with more in-depth analysis is currently under preparation (Dempster et al., in preparation).</p>
    </sec>
    <sec id="Sec17">
      <title>Genome-wide quantification of DNA methylation</title>
      <p>The EZ-96 DNA Methylation kit (Zymo Research, CA, USA) was used to treat 500 ng of DNA from each sample with sodium bisulfite in duplicate. DNA methylation was quantified using the Illumina Infinium HumanMethylation450 BeadChip (Illumina Inc.) run on an Illumina iScan System (Illumina) using the manufacturers’ standard protocol. Samples were randomly assigned to chips and plates to ensure equal distribution of cases and controls across arrays and to minimize batch effects. In addition, a fully methylated control (CpG Methylated HeLa Genomic DNA; New England BioLabs, MA, USA) was included in a random position on each plate.</p>
      <p>Signal intensities were imported in the R programming environment using the <italic>methylumIDAT</italic>() function in the methylumi package [<xref ref-type="bibr" rid="CR51">51</xref>]. Our stringent quality control pipeline included the following steps: (1) checking methylated and unmethylated signal intensities, excluding samples where this was &lt;2500; (2) using the 10 control probes to ensure the bisulfite conversion was successful, excluding any samples with median &lt;90; (3) identifying the fully methylated control sample was in the correct location; (4) all tissues predicted as of blood origin using the tissue prediction from the Epigenetic Clock software (<ext-link ext-link-type="uri" xlink:href="https://dnamage.genetics.ucla.edu/">https://dnamage.genetics.ucla.edu/</ext-link>) [<xref ref-type="bibr" rid="CR21">21</xref>]; (5) multidimensional scaling of sites on X and Y chromosomes separately to confirm reported gender; (6) comparison of genotype data for up to 65 single nucleotide polymorphism (SNP) probes on 450 K array; and (7) use of the <italic>pfilter</italic>() function from wateRmelon package [<xref ref-type="bibr" rid="CR52">52</xref>] to exclude samples with &gt;1 % of probes with detection <italic>P</italic> value &gt; 0.05 and probes with &gt;1 % of samples with detection <italic>P</italic> value &gt; 0.05. PCs were used (calculated across all probes) to identify outliers, samples &gt;2 standard deviations from the mean for both PC1 and PC2 were removed. Finally, we checked the correlation (<italic>r</italic> = 0.927) of reported age with that predicted by the Epigenetic Clock. Normalization of the DNA methylation data was performed used the <italic>dasen</italic>() function in the <italic>wateRmelon</italic> package [<xref ref-type="bibr" rid="CR52">52</xref>]. Due to a different experimental design, the phase 3 cohort was performed so that both members of each MZ twin pair were run on the same chip. Data processing followed a similar pipeline with an additional step using the 65 SNP probes to confirm that twins were genetically identical.</p>
    </sec>
    <sec id="Sec18">
      <title>Genotyping</title>
      <p>Genotyping was performed using the Affymetrix Mapping 500 K Array and the Genomewide Human SNP Array 5.0 or 6.0 (Affymetrix, CA, USA). Genotypes were called from raw intensity data using the Birdseed component of the Birdsuite algorithm [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Samples were genotyped by the Genetic Analysis Platform at The Broad Institute of Harvard and MIT according to standard protocols.</p>
    </sec>
    <sec id="Sec19">
      <title>Imputation</title>
      <p>Prior to imputation, PLINK [<xref ref-type="bibr" rid="CR55">55</xref>] was used to remove samples with &gt;5 % missing data. We also excluded SNPs characterized by &gt;5 % missing values, a Hardy–Weinberg equilibrium <italic>P</italic> value &lt; 0.001 and a minor allele frequency of &lt;5 %. Imputation was performed using ChunkChromosome (<ext-link ext-link-type="uri" xlink:href="http://genome.sph.umich.edu/wiki/ChunkChromosome">http://genome.sph.umich.edu/wiki/ChunkChromosome</ext-link>) and Minimac2 [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>] with the 1000 Genomes reference panel of European samples (phase 1, version 3). Imputed genotypes were then converted back in the PLINK format files using fcgene [<xref ref-type="bibr" rid="CR58">58</xref>] only including variants with Rsq &gt; 0.3. SNPs were then refiltered with PLINK such that they satified the criteria: &lt;1 % missing values, Hardy–Weinburg equilibrium <italic>P</italic>-value &lt; 0.001, and a minor allele frequency of &gt;5 %. Subsequently, SNPs were also filtered so that each of the three genotype groups with zero, one, or two minor alleles (or two genotype groups in the case of rare SNPs with zero or one minor allele) had a minimum of five observations.</p>
    </sec>
    <sec id="Sec20">
      <title>DNA methylation smoking score</title>
      <p>As smoking status information was not present for all samples, we estimated a proxy based on the DNA methylation profile at sites known to be associated with smoking status following the approach in [<xref ref-type="bibr" rid="CR22">22</xref>]. This methodology produces a weighted score across 183 DNA methylation sites, where the weights were taken from the smoking EWAS in [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
    </sec>
    <sec id="Sec21">
      <title>Polygenic risk scores</title>
      <p>As samples from both phase 1 and phase 2 were included in the PGC GWAS of schizophrenia, we obtained the PRS scores from these analyses calculated as part of the leave one out validation experiment, where the training dataset (to derive weights for associated scores) was based on all samples bar one source dataset in which the PRSs were calculated [<xref ref-type="bibr" rid="CR2">2</xref>]. In this analysis we used the scores calculated across an independent set of variants with <italic>P</italic> value &lt; 0.05.</p>
    </sec>
    <sec id="Sec22">
      <title>Statistical analysis</title>
      <p>Probes previously identified as containing a common SNP (allele frequency &gt; 5 % in European populations) within 10 base pairs (bp) of the single base extension position [<xref ref-type="bibr" rid="CR59">59</xref>] or potentially cross-hybridizing to multiple genomic locations [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] were removed prior to analysis. A linear regression model was used to test for differentially methylated sites associated with schizophrenia. DNA methylation values for each probe were regressed against case–control status with covariates for age, gender, and cell composition. As cell count data were not available for these DNA samples, these were estimated from the DNA methylation data using both the Epigenetic Clock software [<xref ref-type="bibr" rid="CR21">21</xref>] and Houseman algorithm [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], including the seven variables recommended in the documentation for the Epigenetic Clock in the regression analysis. Additional regression models including smoking score and principal components, also derived from DNA methylation, were also performed. For the twins a linear model was used to generate regression coefficients, but clustered standard errors using the plm package [<xref ref-type="bibr" rid="CR61">61</xref>] – recognizing individuals from the same twin pair – were used to calculate <italic>P</italic>-values. DMP results are annotated with their genomic location and gene annotation taken from the annotation files provided by Illumina. In addition, transcription factor binding site and DHS site annotation were taken from the supplementary files provided by Slieker and colleagues [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
    </sec>
    <sec id="Sec23">
      <title>Multiple testing threshold</title>
      <p>To establish the multiple testing significance threshold, 5000 permutations were performed repeating the linear regression model for randomly selected groups of cases and controls to match the numbers in the phase 1 data. For each permutation, <italic>P</italic> values from the EWAS were saved and the minimum identified. Across all permutations the fifth percentile was calculated to generate the 5 % alpha significance threshold.</p>
    </sec>
    <sec id="Sec24">
      <title>Regional analysis</title>
      <p>Two different region approaches were used. First, the results for every probe were converted into a BED file (containing genomic location and EWAS <italic>P</italic> value) and run through the <italic>comb-p</italic> [<xref ref-type="bibr" rid="CR28">28</xref>] pipeline with a seed of 5 × 10<sup>−5</sup> and distance parameter set to 500 bp. Briefly, <italic>comb-p</italic> generates DMRs by (1) calculating the auto-correlation between probes to adjust the input DMP <italic>P</italic>-values using the Stouffer–Liptak–Kechris correction, (2) running a peak finding algorithm over these adjusted <italic>P</italic> values to identify enriched regions around a seed signal, (3) calculating the region <italic>P</italic> value using the Stouffer–Liptak correction, and (4) correcting for multiple testing with the one-step Šidák correction. Significant regions were identified as those with at least two probes and a corrected <italic>P</italic> value &lt; 0.05.</p>
      <p>Second, we implemented a sliding window approach with multiple window sizes. Previous EWAS have reported DMRs that span either a few hundred or a few thousand base pairs [<xref ref-type="bibr" rid="CR62">62</xref>]. As is it unlikely that every DMR will contain exactly the same number of probes or have the same genomic span, partly due to the irregular distribution of 450 K probes across the genome [<xref ref-type="bibr" rid="CR63">63</xref>], multiple window sizes were used (100, 200, 500, 1000, 2000, 5000 bp). For each window a combined <italic>P</italic> value was calculated from the individual DMP <italic>P</italic> values contained, taking into account the correlation between probes [<xref ref-type="bibr" rid="CR33">33</xref>]. Each probe on the 450 K array was considered and all probes within the window extended in both directions were collated. The correlation coefficients between each pair of probes in the window and <italic>P</italic> values from the EWAS were combined using Brown’s method for combining non-independent test statistics [<xref ref-type="bibr" rid="CR33">33</xref>]. To derive an appropriate multiple testing threshold (based on 5 % family-wise error), we repeated this procedure on the results of the randomly permuted EWASs separately for each sized window, identified the minimum region <italic>P</italic> value for each permutation, and calculated the fifth percentile. The set of significant regions was then reduced into the best non-overlapping set by ranking all regions by their <italic>P</italic> value, retaining the most significant, and removing any that overlapped (defined as both regions containing any common probes), before moving to the next most significant region, until the bottom of the list was reached.</p>
    </sec>
    <sec id="Sec25">
      <title>Enrichment of regulatory regions</title>
      <p>Published 450 K array probe annotations [<xref ref-type="bibr" rid="CR36">36</xref>] were used to identify probes located in transcription factor binding sites or DHSs based on data made publically available as part of the ENCODE project [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. The overlap between regulatory features and DMPs was tested for enrichment using a two-sided Fisher’s 2 × 2 exact test. The significance level for enrichment of overlap with transcription factor binding sites was calculated using a Bonferroni correction for the 148 different transcription factor binding sites tested.</p>
    </sec>
    <sec id="Sec26">
      <title>Gene ontology analysis</title>
      <p>Illumina UCSC gene annotation, which is derived from the genomic overlap of probes with RefSeq genes or up to 1500 bp of the transcription start site of a gene, was used to create a test gene list from the DMPs for pathway analysis. Where probes were not annotated to any gene (i.e. in the case of intergenic locations), they were omitted from this analysis; where probes were annotated to multiple genes, all were included. A logistic regression approach was used to test if genes in this list predicted pathway membership, while controlling for the number of probes that passed quality control (i.e., were tested) annotated to each gene. Pathways were downloaded from the GO website (<ext-link ext-link-type="uri" xlink:href="http://geneontology.org/">http://geneontology.org/</ext-link>) and mapped to genes, including all parent ontology terms. All genes with at least one 450 K probe annotated and mapped to at least one GO pathway were considered. Pathways were filtered to those containing between 10 and 2000 genes. After applying this method to all pathways, the list of significant pathways (<italic>P</italic> &lt; 0.05) was refined by grouping to control for the effect of overlapping genes. This was achieved by taking the most significant pathway, and retesting all remaining significant pathways while controlling additionally for the best term. If the test genes no longer predicted the pathway, the term was said to be explained by the more significant pathway, and hence these pathways were grouped together. This algorithm was repeated, taking the next most significant term, until all pathways were considered as the most significant or found to be explained by a more significant term.</p>
    </sec>
    <sec id="Sec27">
      <title>Meta-analysis</title>
      <p>All probes with <italic>P</italic> value &lt; 5 × 10<sup>−5</sup> in the phase 1 EWAS were considered for a meta-analysis with phase 2 and phase 3 for case–control analysis only. This was performed using the <italic>metagen</italic>() function in the R package meta [<xref ref-type="bibr" rid="CR64">64</xref>], providing the regression coefficients and standard errors from each individual cohort to calculate weighted pooled estimates and to test for significance. Results from both fixed and random effects models are reported in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Tables S8 and S10; however, we only considered those from the fixed effect model because, with only two or three cohorts, estimates of heterogeneity are poor.</p>
    </sec>
    <sec id="Sec28">
      <title>Overlap with schizophrenia GWAS loci</title>
      <p>The GWAS regions were defined by the PGC in their original manuscript [<xref ref-type="bibr" rid="CR2">2</xref>] and are available for download from the PGC website (<ext-link ext-link-type="uri" xlink:href="https://www.med.unc.edu/pgc/results-and-downloads">https://www.med.unc.edu/pgc/results-and-downloads</ext-link>). Briefly, these were identified by performing a “clumping” procedure on the GWAS <italic>P</italic> values to collapse multiple correlated signals (due to LD) surrounding the index SNP (i.e., with the smallest <italic>P</italic> value) into a single associated region. To define 108 physically distinct loci, those within 250 kb of each other were subsequently merged to obtain the final set of GWAS regions. The outermost SNPs of each associated region define the start and stop parameters of the region. Using the set of 105 autosomal schizophrenia-associated genomic loci we used Brown’s method [<xref ref-type="bibr" rid="CR33">33</xref>] to calculate a combined <italic>P</italic> value across all 450 K probes located within each region. This used the <italic>P</italic> values from both the case–control and PRS EWAS and correlation coefficients between all pairs of probes calculated from the DNA methylation values. This methodology was repeated with the 5000 random permutations we generated. Empirical <italic>P</italic> values for each region were calculated by counting how many of the permutations had more significant <italic>P</italic> values than the true combined <italic>P</italic> value and dividing by the total number of permutations performed.</p>
    </sec>
    <sec id="Sec29">
      <title>Co-localization analyses</title>
      <p>Schizophrenia-associated genomic loci were taken as the 105 autosomal regions published as part of the PGC mega-analysis [<xref ref-type="bibr" rid="CR2">2</xref>]. Given our definition of <italic>cis</italic> mQTLs (i.e., associations between SNPs and DNA methylation probes within 500 kb), all DNA methylation sites located within 500 kb of these regions were identified and <italic>cis</italic> mQTL analysis was performed using MatrixEQTL [<xref ref-type="bibr" rid="CR65">65</xref>]. An additive linear model was fitted to test if the number of alleles (coded 0, 1, or 2) predicted DNA methylation (beta value 0–100) at each site, including covariates for age, sex, and the first two PCs from the genotype data.</p>
      <p>Co-localization analysis was performed as previously described [<xref ref-type="bibr" rid="CR46">46</xref>] using the R coloc package (<ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/web/packages/coloc">http://cran.r-project.org/web/packages/coloc</ext-link>) for each DNA methylation site within each region. From both the PGC schizophrenia GWAS data and our mQTL results we inputted the regression coefficients, their variances, and the SNP minor allele frequencies, and the prior probabilities were left as their default values. This methodology quantifies the support across the results of each GWAS for five hypotheses by calculating the posterior probabilities, denoted as <italic>PPi</italic> for hypothesis <italic>Hi</italic>:<list list-type="bullet"><list-item><p><italic>H</italic><sub><italic>0</italic></sub><italic>: there exist no causal variants for either trait;</italic></p></list-item><list-item><p><italic>H</italic><sub><italic>1</italic></sub><italic>: there exists a causal variant for one trait only, schizophrenia;</italic></p></list-item><list-item><p><italic>H</italic><sub><italic>2</italic></sub><italic>: there exists a causal variant for one trait only, DNA methylation;</italic></p></list-item><list-item><p><italic>H</italic><sub><italic>3</italic></sub><italic>: there exist two distinct causal variants, one for each trait;</italic></p></list-item><list-item><p><italic>H</italic><sub><italic>4</italic></sub><italic>: there exists a single causal variant common to both traits.</italic></p></list-item></list></p>
    </sec>
  </sec>
  <sec id="Sec31">
    <title>Abbreviations</title>
    <p>450K array, Illumina Infinium HumanMethylation450 BeadChip; bp, Base pair; DHS, DNAse I hypersensitivity site; DMP, Differentially methylated positions; DMR, Differentially methylated region; DSM-IV, Diagnostic and Statistical Manual for Mental Disorders fourth edition; EWAS, Epigenome-wide association study; GO, Gene Ontology; GWAS, Genome-wide association study; ICD-10, International Classification of Diseases 10th edition; LD, linkage disequilibrium; MHC, Major histocompatibility complex; mQTL, DNA methylation quantitative trait loci; MZ, Monozygotic; OPCRIT, Operational Criteria Checklist; OR, Odds ratio; PC, Principal component; PGC, Psychiatric Genomics Consortium; PRS, Polygenic risk score; RDC, Research diagnostic criteria; SADS-L, Schedule for Affective Disorders and Schizophrenia-Lifetime Version; SCID, Structured Clinical Interview for DSM-IV; SNP, single nucleotide polymorphism</p>
  </sec>
</body>
<back>
  <app-group>
    <app id="App1">
      <sec id="Sec30">
        <title>Additional files</title>
        <p>
          <media position="anchor" xlink:href="13059_2016_1041_MOESM1_ESM.pdf" id="MOESM1">
            <label>Additional file 1: Figures S1–S17.</label>
            <caption>
              <p>(PDF 1469 kb)</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="13059_2016_1041_MOESM2_ESM.xlsx" id="MOESM2">
            <label>Additional file 2:</label>
            <caption>
              <p>Supplementary Tables S1-S11. (XLSX 6.83 mb)</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="13059_2016_1041_MOESM3_ESM.pdf" id="MOESM3">
            <label>Additional file 3:</label>
            <caption>
              <p>Forest plots from case–control meta-analyses. (PDF 462 kb)</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="13059_2016_1041_MOESM4_ESM.pdf" id="MOESM4">
            <label>Additional file 4:</label>
            <caption>
              <p>Examples of co-localization between variants associated with schizophrenia and DNA methylation. (PDF 335 kb)</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="13059_2016_1041_MOESM5_ESM.xlsx" id="MOESM5">
            <label>Additional file 5:</label>
            <caption>
              <p>The DNA methylation values for the specific probes used in the MZ twin replication analysis. (XLSX 3313 kb)</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="13059_2016_1041_MOESM6_ESM.xlsx" id="MOESM6">
            <label>Additional file 6:</label>
            <caption>
              <p>The phenotype data for the samples used in the MZ twin replication analysis. (XLSX 16 kb)</p>
            </caption>
          </media>
        </p>
      </sec>
    </app>
  </app-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We thank Dr Hannah Elliott (University of Bristol MRC Integrative Epidemiology Unit) for providing code to calculate DNA methylation smoking scores.</p>
    <sec id="FPar1">
      <title>Funding</title>
      <p>This work was primarily supported by grants from the UK Medical Research Council (MRC; MR/K013807/1) to JM and the US National Institutes of Health (NIH) (R01 AG036039) to JM. The Finnish Twin study was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (grant numbers: 213506, 129680), and JK by the Academy of Finland grants 265240 and 263278. Financial support for the Swedish twin study was provided by the Karolinska Institutet (ALF 20090183 and ALF 20100305) and NIH (R01 MH52857).</p>
    </sec>
    <sec id="FPar2">
      <title>Availability of data and materials</title>
      <p>Illumina 450 K array data has been uploaded to the Gene Expression Omnibus and is available under accession numbers [GEO:GSE80417] (phase 1 cohort) and [GEO:GSE84727] (phase 2 cohort). Data for the specific probes used in the MZ twin replication analysis are available in Additional files <xref rid="MOESM5" ref-type="media">5</xref> and <xref rid="MOESM6" ref-type="media">6</xref>. Code used in the analyses is available to download from <ext-link ext-link-type="uri" xlink:href="https://github.com/ejh243/SCZEWAS">https://github.com/ejh243/SCZEWAS</ext-link>; this software is licensed under GNU General Public License version 2.0 and deposited at Zenado.org under doi 10.5281/zenodo.58338.</p>
    </sec>
    <sec id="FPar3">
      <title>Authors’ contributions</title>
      <p>JM obtained funding and supervised the project. EH undertook primary statistical and bioinformatics analyses. ED, JB, AS, and RM undertook laboratory work. ED undertook analysis of MZ twins. EH and JM drafted the manuscript. GB, DC, RMM, and LS were co-applicants on funding application. LS, JV, and ED provided bioinformatics support. DSC, CM, ST, JK, TT, HP, MB, RK, IN, CH, RMM, NB, HG, and AM provided samples and genotype data. All authors read and approved the final manuscript.</p>
    </sec>
    <sec id="FPar4">
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec id="FPar5">
      <title>Ethics approval and consent to participate</title>
      <p>The study was approved by the University of Exeter Medical School Research Ethics Committee (reference number 13/02/009).</p>
    </sec>
  </ack>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Whiteford</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Degenhardt</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rehm</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Baxter</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Ferrari</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Erskine</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Charlson</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Norman</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Flaxman</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Johns</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010</article-title>
        <source>Lancet.</source>
        <year>2013</year>
        <volume>382</volume>
        <fpage>1575</fpage>
        <lpage>1586</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61611-6</pub-id>
        <?supplied-pmid 23993280?>
        <pub-id pub-id-type="pmid">23993280</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Schizophrenia Working Group of the PGC</collab>
          <name>
            <surname>Ripke</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Neale</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Corvin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Farh</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Holmans</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bulik-Sullivan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Collier</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
        <source>Nature</source>
        <year>2014</year>
        <volume>511</volume>
        <fpage>421</fpage>
        <lpage>427</lpage>
        <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
        <pub-id pub-id-type="pmid">25056061</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maurano</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Humbert</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rynes</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Thurman</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Haugen</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Sandstrom</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Brody</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Systematic localization of common disease-associated variation in regulatory DNA</article-title>
        <source>Science.</source>
        <year>2012</year>
        <volume>337</volume>
        <fpage>1190</fpage>
        <lpage>1195</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1222794</pub-id>
        <?supplied-pmid 22955828?>
        <pub-id pub-id-type="pmid">22955828</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ernst</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kheradpour</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mikkelsen</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Shoresh</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Issner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Coyne</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mapping and analysis of chromatin state dynamics in nine human cell types</article-title>
        <source>Nature.</source>
        <year>2011</year>
        <volume>473</volume>
        <fpage>43</fpage>
        <lpage>49</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09906</pub-id>
        <?supplied-pmid 21441907?>
        <pub-id pub-id-type="pmid">21441907</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schaub</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Boyle</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Kundaje</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Batzoglou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Snyder</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Linking disease associations with regulatory information in the human genome</article-title>
        <source>Genome Res.</source>
        <year>2012</year>
        <volume>22</volume>
        <fpage>1748</fpage>
        <lpage>1759</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.136127.111</pub-id>
        <?supplied-pmid 22955986?>
        <pub-id pub-id-type="pmid">22955986</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagner</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Busche</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kwan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pastinen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Blanchette</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts</article-title>
        <source>Genome Biol.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>R37</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r37</pub-id>
        <?supplied-pmid 24555846?>
        <pub-id pub-id-type="pmid">24555846</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maunakea</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Nagarajan</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Bilenky</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ballinger</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>D’Souza</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fouse</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Conserved role of intragenic DNA methylation in regulating alternative promoters</article-title>
        <source>Nature.</source>
        <year>2010</year>
        <volume>466</volume>
        <fpage>253</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09165</pub-id>
        <?supplied-pmid 20613842?>
        <pub-id pub-id-type="pmid">20613842</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murphy</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Mill</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Epigenetics in health and disease: heralding the EWAS era</article-title>
        <source>Lancet.</source>
        <year>2014</year>
        <volume>383</volume>
        <fpage>1952</fpage>
        <lpage>1954</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60269-5</pub-id>
        <?supplied-pmid 24630775?>
        <pub-id pub-id-type="pmid">24630775</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mill</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Heijmans</surname>
            <given-names>BT</given-names>
          </name>
        </person-group>
        <article-title>From promises to practical strategies in epigenetic epidemiology</article-title>
        <source>Nat Rev Genet.</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>585</fpage>
        <lpage>594</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3405</pub-id>
        <?supplied-pmid 23817309?>
        <pub-id pub-id-type="pmid">23817309</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Relton</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Davey Smith</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment</article-title>
        <source>PLoS Med.</source>
        <year>2010</year>
        <volume>7</volume>
        <fpage>e1000356</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pmed.1000356</pub-id>
        <?supplied-pmid 21048988?>
        <pub-id pub-id-type="pmid">21048988</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rakyan</surname>
            <given-names>VK</given-names>
          </name>
          <name>
            <surname>Down</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Balding</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Epigenome-wide association studies for common human diseases</article-title>
        <source>Nat Rev Genet.</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>529</fpage>
        <lpage>541</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3000</pub-id>
        <?supplied-pmid 21747404?>
        <pub-id pub-id-type="pmid">21747404</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dempster</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Pidsley</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schalkwyk</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Owens</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Georgiades</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kane</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kalidindi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Picchioni</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kravariti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Toulopoulou</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder</article-title>
        <source>Hum Mol Genet.</source>
        <year>2011</year>
        <volume>20</volume>
        <fpage>4786</fpage>
        <lpage>4796</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddr416</pub-id>
        <?supplied-pmid 21908516?>
        <pub-id pub-id-type="pmid">21908516</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aberg</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>McClay</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Nerella</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Khachane</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hudson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults</article-title>
        <source>JAMA Psychiatry.</source>
        <year>2014</year>
        <volume>71</volume>
        <fpage>255</fpage>
        <lpage>264</lpage>
        <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.3730</pub-id>
        <?supplied-pmid 24402055?>
        <pub-id pub-id-type="pmid">24402055</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kinoshita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Numata</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tajima</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ohi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hashimoto</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shimodera</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Imoto</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Takeda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ohmori</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportions</article-title>
        <source>Neuromolecular Med.</source>
        <year>2014</year>
        <volume>16</volume>
        <fpage>697</fpage>
        <lpage>703</lpage>
        <pub-id pub-id-type="doi">10.1007/s12017-014-8319-5</pub-id>
        <?supplied-pmid 25052007?>
        <pub-id pub-id-type="pmid">25052007</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pidsley</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Viana</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hannon</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Spiers</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Troakes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Al-Saraj</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mechawar</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Turecki</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Schalkwyk</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Bray</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Mill</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia</article-title>
        <source>Genome Biol.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>483</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-014-0483-2</pub-id>
        <?supplied-pmid 25347937?>
        <pub-id pub-id-type="pmid">25347937</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wockner</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>EP</given-names>
          </name>
          <name>
            <surname>Lawford</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Whitehall</surname>
            <given-names>VL</given-names>
          </name>
          <name>
            <surname>Voisey</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients</article-title>
        <source>Transl Psychiatry.</source>
        <year>2014</year>
        <volume>4</volume>
        <fpage>e339</fpage>
        <pub-id pub-id-type="doi">10.1038/tp.2013.111</pub-id>
        <?supplied-pmid 24399042?>
        <pub-id pub-id-type="pmid">24399042</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Jaffe AE, Gao Y, Deep-Soboslay A, Tao R, Hyde TM, Weinberger DR, Kleinman JE. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci. 2015;19(1):40–7.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <mixed-citation publication-type="other">Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM, Troakes C, Turecki G, O’Donovan MC, Schalkwyk LC, et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat Neurosci. 2015;19(1):48–54.</mixed-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Houseman</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Accomando</surname>
            <given-names>WP</given-names>
          </name>
          <name>
            <surname>Koestler</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Christensen</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Marsit</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Wiencke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Kelsey</surname>
            <given-names>KT</given-names>
          </name>
        </person-group>
        <article-title>DNA methylation arrays as surrogate measures of cell mixture distribution</article-title>
        <source>BMC Bioinformatics.</source>
        <year>2012</year>
        <volume>13</volume>
        <fpage>86</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-13-86</pub-id>
        <?supplied-pmid 22568884?>
        <pub-id pub-id-type="pmid">22568884</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koestler</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Christensen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Karagas</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Marsit</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Langevin</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Kelsey</surname>
            <given-names>KT</given-names>
          </name>
          <name>
            <surname>Wiencke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Houseman</surname>
            <given-names>EA</given-names>
          </name>
        </person-group>
        <article-title>Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis</article-title>
        <source>Epigenetics.</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>816</fpage>
        <lpage>826</lpage>
        <pub-id pub-id-type="doi">10.4161/epi.25430</pub-id>
        <?supplied-pmid 23903776?>
        <pub-id pub-id-type="pmid">23903776</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Horvath</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>DNA methylation age of human tissues and cell types</article-title>
        <source>Genome Biol.</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>R115</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id>
        <?supplied-pmid 24138928?>
        <pub-id pub-id-type="pmid">24138928</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Elliott</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Tillin</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>McArdle</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Duggirala</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Frayling</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Davey Smith</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hughes</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Chaturvedi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Relton</surname>
            <given-names>CL</given-names>
          </name>
        </person-group>
        <article-title>Differences in smoking associated DNA methylation patterns in South Asians and Europeans</article-title>
        <source>Clin Epigenetics.</source>
        <year>2014</year>
        <volume>6</volume>
        <fpage>4</fpage>
        <pub-id pub-id-type="doi">10.1186/1868-7083-6-4</pub-id>
        <?supplied-pmid 24485148?>
        <pub-id pub-id-type="pmid">24485148</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeilinger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kühnel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Klopp</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Baurecht</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kleinschmidt</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gieger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Weidinger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lattka</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Adamski</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tobacco smoking leads to extensive genome-wide changes in DNA methylation</article-title>
        <source>PLoS One.</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>e63812</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0063812</pub-id>
        <?supplied-pmid 23691101?>
        <pub-id pub-id-type="pmid">23691101</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tsaprouni</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>TP</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dick</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kanoni</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nisbet</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Viñuela</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grundberg</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Meduri</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation</article-title>
        <source>Epigenetics.</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>1382</fpage>
        <lpage>1396</lpage>
        <pub-id pub-id-type="doi">10.4161/15592294.2014.969637</pub-id>
        <?supplied-pmid 25424692?>
        <pub-id pub-id-type="pmid">25424692</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Leon</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Becoña</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gurpegui</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gonzalez-Pinto</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Diaz</surname>
            <given-names>FJ</given-names>
          </name>
        </person-group>
        <article-title>The association between high nicotine dependence and severe mental illness may be consistent across countries</article-title>
        <source>J Clin Psychiatry.</source>
        <year>2002</year>
        <volume>63</volume>
        <fpage>812</fpage>
        <lpage>816</lpage>
        <pub-id pub-id-type="doi">10.4088/JCP.v63n0911</pub-id>
        <?supplied-pmid 12363123?>
        <pub-id pub-id-type="pmid">12363123</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McClave</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>McKnight-Eily</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Dube</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey</article-title>
        <source>Am J Public Health.</source>
        <year>2010</year>
        <volume>100</volume>
        <fpage>2464</fpage>
        <lpage>2472</lpage>
        <pub-id pub-id-type="doi">10.2105/AJPH.2009.188136</pub-id>
        <?supplied-pmid 20966369?>
        <pub-id pub-id-type="pmid">20966369</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Leon</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Diaz</surname>
            <given-names>FJ</given-names>
          </name>
        </person-group>
        <article-title>A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors</article-title>
        <source>Schizophr Res.</source>
        <year>2005</year>
        <volume>76</volume>
        <fpage>135</fpage>
        <lpage>157</lpage>
        <pub-id pub-id-type="doi">10.1016/j.schres.2005.02.010</pub-id>
        <?supplied-pmid 15949648?>
        <pub-id pub-id-type="pmid">15949648</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pedersen</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>IV</given-names>
          </name>
          <name>
            <surname>Kechris</surname>
            <given-names>KJ</given-names>
          </name>
        </person-group>
        <article-title>Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values</article-title>
        <source>Bioinformatics.</source>
        <year>2012</year>
        <volume>28</volume>
        <fpage>2986</fpage>
        <lpage>2988</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts545</pub-id>
        <?supplied-pmid 22954632?>
        <pub-id pub-id-type="pmid">22954632</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Schizophrenia Working Group of the PGC</collab>
          <name>
            <surname>Ripke</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sanders</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kendler</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Levinson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Holmans</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ophoff</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association study identifies five new schizophrenia loci</article-title>
        <source>Nat Genet</source>
        <year>2011</year>
        <volume>43</volume>
        <fpage>969</fpage>
        <lpage>U977</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.940</pub-id>
        <pub-id pub-id-type="pmid">21926974</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Schizophrenia Working Group of the PGC</collab>
          <name>
            <surname>Ripke</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>O’Dushlaine</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chambert</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Moran</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kahler</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Akterin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bergen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Crowley</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association analysis identifies 13 new risk loci for schizophrenia</article-title>
        <source>Nat Genet</source>
        <year>2013</year>
        <volume>45</volume>
        <fpage>1150</fpage>
        <lpage>U1282</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2742</pub-id>
        <pub-id pub-id-type="pmid">23974872</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Levinson</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sanders</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Pe'er</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Dudbridge</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Holmans</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Whittemore</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Mowry</surname>
            <given-names>BJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Common variants on chromosome 6p22.1 are associated with schizophrenia</article-title>
        <source>Nature</source>
        <year>2009</year>
        <volume>460</volume>
        <fpage>753</fpage>
        <lpage>757</lpage>
        <?supplied-pmid 19571809?>
        <pub-id pub-id-type="pmid">19571809</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <mixed-citation publication-type="other">Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177–83.</mixed-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>MB</given-names>
          </name>
        </person-group>
        <article-title>A method for combining non-independent, one-sided tests of significance</article-title>
        <source>Biometrics.</source>
        <year>1975</year>
        <volume>31</volume>
        <fpage>987</fpage>
        <lpage>992</lpage>
        <pub-id pub-id-type="doi">10.2307/2529826</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arion</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Corradi</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Datta</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Boothe</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cacace</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Zaczek</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Albright</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder</article-title>
        <source>Mol Psychiatry.</source>
        <year>2015</year>
        <volume>20</volume>
        <fpage>1397</fpage>
        <lpage>1405</lpage>
        <pub-id pub-id-type="doi">10.1038/mp.2014.171</pub-id>
        <?supplied-pmid 25560755?>
        <pub-id pub-id-type="pmid">25560755</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>ENCODE Project Consortium</collab>
        </person-group>
        <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>489</volume>
        <fpage>57</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11247</pub-id>
        <pub-id pub-id-type="pmid">22955616</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Slieker</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Bos</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Goeman</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Bovée</surname>
            <given-names>JV</given-names>
          </name>
          <name>
            <surname>Talens</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>van der Breggen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Suchiman</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Lameijer</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Putter</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>van den Akker</surname>
            <given-names>EB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450 k array</article-title>
        <source>Epigenetics Chromatin.</source>
        <year>2013</year>
        <volume>6</volume>
        <fpage>26</fpage>
        <pub-id pub-id-type="doi">10.1186/1756-8935-6-26</pub-id>
        <?supplied-pmid 23919675?>
        <pub-id pub-id-type="pmid">23919675</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium</collab>
        </person-group>
        <article-title>Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</article-title>
        <source>Nat Neurosci</source>
        <year>2015</year>
        <volume>18</volume>
        <fpage>199</fpage>
        <lpage>209</lpage>
        <pub-id pub-id-type="doi">10.1038/nn.3922</pub-id>
        <pub-id pub-id-type="pmid">25599223</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mistry</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gillis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pavlidis</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide expression profiling of schizophrenia using a large combined cohort</article-title>
        <source>Mol Psychiatry.</source>
        <year>2013</year>
        <volume>18</volume>
        <fpage>215</fpage>
        <lpage>225</lpage>
        <pub-id pub-id-type="doi">10.1038/mp.2011.172</pub-id>
        <?supplied-pmid 22212594?>
        <pub-id pub-id-type="pmid">22212594</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roussos</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Katsel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Siever</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Haroutunian</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples</article-title>
        <source>Arch Gen Psychiatry.</source>
        <year>2012</year>
        <volume>69</volume>
        <fpage>1205</fpage>
        <lpage>1213</lpage>
        <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2012.704</pub-id>
        <?supplied-pmid 22868662?>
        <pub-id pub-id-type="pmid">22868662</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nielsen</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Laursen</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Mortensen</surname>
            <given-names>PB</given-names>
          </name>
        </person-group>
        <article-title>Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood</article-title>
        <source>Schizophr Bull.</source>
        <year>2013</year>
        <volume>39</volume>
        <fpage>230</fpage>
        <lpage>237</lpage>
        <pub-id pub-id-type="doi">10.1093/schbul/sbr149</pub-id>
        <?supplied-pmid 22021661?>
        <pub-id pub-id-type="pmid">22021661</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sørensen</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Mortensen</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Reinisch</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Mednick</surname>
            <given-names>SA</given-names>
          </name>
        </person-group>
        <article-title>Association between prenatal exposure to bacterial infection and risk of schizophrenia</article-title>
        <source>Schizophr Bull.</source>
        <year>2009</year>
        <volume>35</volume>
        <fpage>631</fpage>
        <lpage>637</lpage>
        <pub-id pub-id-type="doi">10.1093/schbul/sbn121</pub-id>
        <?supplied-pmid 18832344?>
        <pub-id pub-id-type="pmid">18832344</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weinberger</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>From neuropathology to neurodevelopment</article-title>
        <source>Lancet.</source>
        <year>1995</year>
        <volume>346</volume>
        <fpage>552</fpage>
        <lpage>557</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(95)91386-6</pub-id>
        <?supplied-pmid 7544856?>
        <pub-id pub-id-type="pmid">7544856</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Purcell</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Wray</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Stone</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Visscher</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>O’Donovan</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>P</given-names>
          </name>
          <collab>International Schizophrenia Consortium</collab>
        </person-group>
        <article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>
        <source>Nature</source>
        <year>2009</year>
        <volume>460</volume>
        <fpage>748</fpage>
        <lpage>752</lpage>
        <?supplied-pmid 19571811?>
        <pub-id pub-id-type="pmid">19571811</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">van Eijk KR, de Jong S, Strengman E, Buizer-Voskamp JE, Kahn RS, Boks MP, Horvath S, Ophoff RA. Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood. Eur J Hum Genet. 2014;23(8):1106–10.</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>McClay</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Shabalin</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Adkins</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nerella</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>PF</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Refinement of schizophrenia GWAS loci using methylome-wide association data</article-title>
        <source>Hum Genet.</source>
        <year>2015</year>
        <volume>134</volume>
        <fpage>77</fpage>
        <lpage>87</lpage>
        <pub-id pub-id-type="doi">10.1007/s00439-014-1494-5</pub-id>
        <?supplied-pmid 25284466?>
        <pub-id pub-id-type="pmid">25284466</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giambartolomei</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vukcevic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Schadt</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Franke</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hingorani</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Plagnol</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Bayesian test for colocalisation between pairs of genetic association studies using summary statistics</article-title>
        <source>PLoS Genet.</source>
        <year>2014</year>
        <volume>10</volume>
        <fpage>e1004383</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1004383</pub-id>
        <?supplied-pmid 24830394?>
        <pub-id pub-id-type="pmid">24830394</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fortune</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Burren</surname>
            <given-names>OS</given-names>
          </name>
          <name>
            <surname>Schofield</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Todd</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases</article-title>
        <source>Hum Mol Genet.</source>
        <year>2015</year>
        <volume>24</volume>
        <fpage>3305</fpage>
        <lpage>3313</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddv077</pub-id>
        <?supplied-pmid 25743184?>
        <pub-id pub-id-type="pmid">25743184</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Datta</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>McQuillin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rizig</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Blaveri</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Thirumalai</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kalsi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Lawrence</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bass</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Puri</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Choudhury</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia</article-title>
        <source>Mol Psychiatry.</source>
        <year>2010</year>
        <volume>15</volume>
        <fpage>615</fpage>
        <lpage>628</lpage>
        <pub-id pub-id-type="doi">10.1038/mp.2008.128</pub-id>
        <?supplied-pmid 19048012?>
        <pub-id pub-id-type="pmid">19048012</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Spitzer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Endicott</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <source>The schedule for affective disorders and schizophrenia, lifetime version</source>
        <year>1977</year>
        <edition>3</edition>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>New York State Psychiatric Institute</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>International Schizophrenia Consortium</collab>
        </person-group>
        <article-title>Rare chromosomal deletions and duplications increase risk of schizophrenia</article-title>
        <source>Nature</source>
        <year>2008</year>
        <volume>455</volume>
        <fpage>237</fpage>
        <lpage>241</lpage>
        <pub-id pub-id-type="doi">10.1038/nature07239</pub-id>
        <pub-id pub-id-type="pmid">18668038</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <mixed-citation publication-type="other">Davis S, Du P, Bilke S, Triche J, Bootwalla M. methylumi: Handle Illumina methylation data. R package version 2.14.0. 2015.</mixed-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pidsley</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>CCY</given-names>
          </name>
          <name>
            <surname>Volta</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lunnon</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mill</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schalkwyk</surname>
            <given-names>LC</given-names>
          </name>
        </person-group>
        <article-title>A data-driven approach to preprocessing Illumina 450 K methylation array data</article-title>
        <source>BMC Genomics.</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>293</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-14-293</pub-id>
        <?supplied-pmid 23631413?>
        <pub-id pub-id-type="pmid">23631413</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Korn</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Kuruvilla</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>McCarroll</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Wysoker</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nemesh</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cawley</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hubbell</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Veitch</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Darvishi</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs</article-title>
        <source>Nat Genet.</source>
        <year>2008</year>
        <volume>40</volume>
        <fpage>1253</fpage>
        <lpage>1260</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.237</pub-id>
        <?supplied-pmid 18776909?>
        <pub-id pub-id-type="pmid">18776909</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCarroll</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Kuruvilla</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Korn</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Cawley</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nemesh</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wysoker</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Shapero</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>de Bakker</surname>
            <given-names>PI</given-names>
          </name>
          <name>
            <surname>Maller</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Kirby</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrated detection and population-genetic analysis of SNPs and copy number variation</article-title>
        <source>Nat Genet.</source>
        <year>2008</year>
        <volume>40</volume>
        <fpage>1166</fpage>
        <lpage>1174</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.238</pub-id>
        <?supplied-pmid 18776908?>
        <pub-id pub-id-type="pmid">18776908</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Purcell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Neale</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Todd-Brown</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ferreira</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Bender</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Maller</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>de Bakker</surname>
            <given-names>PI</given-names>
          </name>
          <name>
            <surname>Daly</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Sham</surname>
            <given-names>PC</given-names>
          </name>
        </person-group>
        <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>
        <source>Am J Hum Genet.</source>
        <year>2007</year>
        <volume>81</volume>
        <fpage>559</fpage>
        <lpage>575</lpage>
        <pub-id pub-id-type="doi">10.1086/519795</pub-id>
        <?supplied-pmid 17701901?>
        <pub-id pub-id-type="pmid">17701901</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fuchsberger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Hinds</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>minimac2: faster genotype imputation</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>31</volume>
        <fpage>782</fpage>
        <lpage>784</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu704</pub-id>
        <?supplied-pmid 25338720?>
        <pub-id pub-id-type="pmid">25338720</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Howie</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Fuchsberger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stephens</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Fast and accurate genotype imputation in genome-wide association studies through pre-phasing</article-title>
        <source>Nat Genet.</source>
        <year>2012</year>
        <volume>44</volume>
        <fpage>955</fpage>
        <lpage>959</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2354</pub-id>
        <?supplied-pmid 22820512?>
        <pub-id pub-id-type="pmid">22820512</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roshyara</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Scholz</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>fcGENE: a versatile tool for processing and transforming SNP datasets</article-title>
        <source>PLoS One</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e97589</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0097589</pub-id>
        <?supplied-pmid 25050709?>
        <pub-id pub-id-type="pmid">25050709</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Lemire</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Choufani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Butcher</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Grafodatskaya</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zanke</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Gallinger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hudson</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Weksberg</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray</article-title>
        <source>Epigenetics.</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>203</fpage>
        <lpage>209</lpage>
        <pub-id pub-id-type="doi">10.4161/epi.23470</pub-id>
        <?supplied-pmid 23314698?>
        <pub-id pub-id-type="pmid">23314698</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Price</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Cotton</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Lam</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Farré</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Emberly</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>WP</given-names>
          </name>
          <name>
            <surname>Kobor</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array</article-title>
        <source>Epigenetics Chromatin.</source>
        <year>2013</year>
        <volume>6</volume>
        <fpage>4</fpage>
        <pub-id pub-id-type="doi">10.1186/1756-8935-6-4</pub-id>
        <?supplied-pmid 23452981?>
        <pub-id pub-id-type="pmid">23452981</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <mixed-citation publication-type="other">Croissant Y, Millo G. Panel data econometrics in R: The plm package. J Stat Softw. 2008;27(2).</mixed-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bock</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Analysing and interpreting DNA methylation data</article-title>
        <source>Nat Rev Genet</source>
        <year>2012</year>
        <volume>13</volume>
        <fpage>705</fpage>
        <lpage>719</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3273</pub-id>
        <?supplied-pmid 22986265?>
        <pub-id pub-id-type="pmid">22986265</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feber</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Guilhamon</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lechner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fenton</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Thirlwell</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Flanagan</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Teschendorff</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Kelly</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Using high-density DNA methylation arrays to profile copy number alterations</article-title>
        <source>Genome Biol.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>R30</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r30</pub-id>
        <?supplied-pmid 24490765?>
        <pub-id pub-id-type="pmid">24490765</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <mixed-citation publication-type="other">Schwarzer G. meta: General package for meta-analysis. 2015. Available from <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/meta/">https://cran.r-project.org/web/packages/meta/</ext-link>. Accessed 17 Aug 2016.</mixed-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shabalin</surname>
            <given-names>AA</given-names>
          </name>
        </person-group>
        <article-title>Matrix eQTL: ultra fast eQTL analysis via large matrix operations</article-title>
        <source>Bioinformatics.</source>
        <year>2012</year>
        <volume>28</volume>
        <fpage>1353</fpage>
        <lpage>1358</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts163</pub-id>
        <?supplied-pmid 22492648?>
        <pub-id pub-id-type="pmid">22492648</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
